• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by GENENTA SCIENCE SPA

    Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
    From GENENTA SCIENCE SPA
    Via GlobeNewswire
    Tickers GNTA
    Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
    From GENENTA SCIENCE SPA
    Via GlobeNewswire
    Tickers GNTA
    Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
    From GENENTA SCIENCE SPA
    Via GlobeNewswire
    Tickers ARYD GNTA SQZ
    Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
    From GENENTA SCIENCE SPA
    Via GlobeNewswire
    Tickers GNTA
    Genenta to Present at Upcoming Scientific and Investor Conferences
    From GENENTA SCIENCE SPA
    Via GlobeNewswire
    Tickers GNTA
    Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments
    From GENENTA SCIENCE SPA
    Via GlobeNewswire
    Tickers GNTA
    The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
    From GENENTA SCIENCE SPA
    Via GlobeNewswire
    Tickers GNTA
    Genenta to Provide Update on Lead Product Temferon™
    From GENENTA SCIENCE SPA
    Via GlobeNewswire
    Tickers GNTA
    Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
    From GENENTA SCIENCE SPA
    Via GlobeNewswire
    Tickers GNTA
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.